IL299287A - Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis - Google Patents

Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis

Info

Publication number
IL299287A
IL299287A IL299287A IL29928722A IL299287A IL 299287 A IL299287 A IL 299287A IL 299287 A IL299287 A IL 299287A IL 29928722 A IL29928722 A IL 29928722A IL 299287 A IL299287 A IL 299287A
Authority
IL
Israel
Prior art keywords
kits
methods
dosing regimen
dose combination
combination products
Prior art date
Application number
IL299287A
Other languages
English (en)
Hebrew (he)
Original Assignee
Redhill Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redhill Biopharma Ltd filed Critical Redhill Biopharma Ltd
Publication of IL299287A publication Critical patent/IL299287A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL299287A 2020-06-30 2021-06-30 Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis IL299287A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063046322P 2020-06-30 2020-06-30
US202063046335P 2020-06-30 2020-06-30
PCT/IB2021/000451 WO2022003421A2 (en) 2020-06-30 2021-06-30 Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

Publications (1)

Publication Number Publication Date
IL299287A true IL299287A (en) 2023-02-01

Family

ID=79032054

Family Applications (1)

Application Number Title Priority Date Filing Date
IL299287A IL299287A (en) 2020-06-30 2021-06-30 Fixed-dose triple antibiotic combination products, dosing regimen, methods, and kits for the treatment of pulmonary mycobacterial infections other than tuberculosis

Country Status (11)

Country Link
US (1) US11590154B2 (enExample)
EP (1) EP4171546A4 (enExample)
JP (1) JP2023533472A (enExample)
KR (1) KR20230028502A (enExample)
CN (1) CN115768420A (enExample)
AU (1) AU2021298936A1 (enExample)
BR (1) BR112022026615A2 (enExample)
CA (1) CA3187031A1 (enExample)
IL (1) IL299287A (enExample)
MX (1) MX2023000165A (enExample)
WO (1) WO2022003421A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025026423A1 (en) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, their use and manufacture for treatment of gastrointestinal conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0971735T1 (sl) 1997-04-01 2008-08-31 Borody Thomas J Postopek in sestavina za zdravljenje bolezni vnetja debelega äśrevesa
CA2714043C (en) 2008-02-08 2016-11-08 Giaconda Limited Methods and compositions for treating inflammatory bowel disease
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
CA3000709A1 (en) 2015-10-01 2017-04-06 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2017194734A1 (en) 2016-05-13 2017-11-16 Technische Universität München Means and methods for treating mycobacterial diseases

Also Published As

Publication number Publication date
US11590154B2 (en) 2023-02-28
EP4171546A2 (en) 2023-05-03
CN115768420A (zh) 2023-03-07
AU2021298936A1 (en) 2023-01-19
WO2022003421A3 (en) 2022-03-17
BR112022026615A2 (pt) 2023-01-24
JP2023533472A (ja) 2023-08-03
US20210401865A1 (en) 2021-12-30
WO2022003421A2 (en) 2022-01-06
MX2023000165A (es) 2023-02-22
KR20230028502A (ko) 2023-02-28
CA3187031A1 (en) 2022-01-06
EP4171546A4 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
LT4067387T (lt) Anti-pd-1-anti-vegfa bispecifinis antikūnas, farmacinė kompozicija ir jos panaudojimas
EP3805264A4 (en) ANTI-INTERLEUKIN 17A ANTIBODIES, PHARMACEUTICAL COMPOSITION AND USE
IL275798A (en) Methods for antibody drug conjugation, purification and formulation
EP3279217A4 (en) Streptococcus pneumoniae protein antigen, and preparation method and use thereof
DK3968983T3 (da) Makrocykliske, bredspektrede antibiotika
EP4095232A4 (en) BACTERIA, COMPOSITION AND PRODUCTION METHOD THEREFOR, AND COMPOSITION OF PREBIOTICS
IL288953A (en) Pharmaceutical compounds, kits and methods for the treatment of cancerous tumors
EP3846825A4 (en) FORMULATIONS AND COMPOSITIONS FOR ORTHO- AND/OR RETRO-NASAL DELIVERY AND RELATED SYSTEMS, METHODS AND ARTICLES
EP4130381A4 (en) METHOD FOR PRODUCING A ROAD BASE COURSE AND MIXTURE FOR USE IN THIS METHOD
EP4248964A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEPSIS AND USE THEREOF
EP4477733A4 (en) COMPOSITION, MANUFACTURING METHOD AND USE
ZA202102932B (en) Methods, devices, kits and compositions for detecting tapeworm
EP4620468A4 (en) BUTADIENE-CYCLODEXTRIN INCLUSION COMPLEX, PHARMACEUTICAL COMPOSITION, PROCESS OF PREPARATION AND ASSOCIATED USE
SG11202109359RA (en) Composition comprising block copolymer, and method for producing siliceous film using the same
EP3974445A4 (en) BISPECIFIC MOLECULE, ITS MANUFACTURE AND USE
EP3936530A4 (en) ABSORBENT BODY, ABSORBENT ARTICLE AND METHOD OF ADJUSTING THE PERMEATION RATE
IL284980B1 (en) Heteroaryl-azacyclic-oxo-amide compound, pharmaceutical preparation and pharmaceutical preparation for use in the treatment
EP4135753A4 (en) METHODS, COMPOSITIONS AND THEIR USES FOR REVERSING SARCOPENIA
EP4039857A4 (en) AGENT PROVIDING A FRESH-ON-CONTACT FEELING AND WATER-ABSORBING/QUICK-DRYING PROPERTIES, AND METHOD FOR PROVIDING A COOL-ON-CONTACT FEELING AND WATER-ABSORBING/QUICK-DRYING PROPERTIES TO AN ARTICLE
GB202107977D0 (en) Method, composition and use
EP4067307A4 (en) HIGHLY WEAR-RESISTANT ZEOLITE MOLDED ARTICLE AND METHOD FOR MANUFACTURING THE SAME
EP4039717A4 (en) COMPOSITION OF WATER-REPELLENT AND OIL-REPELLENT AGENT, METHOD FOR PRODUCTION THEREOF AND ARTICLE
EP3909607A4 (en) PHARMACEUTICAL COMPOSITION WITH ANTIBODIES, DEVICE CONTAINING THIS AND USE THEREOF
GB202117111D0 (en) Antibodies for use as therapeutics against bacterial infections
GB2627873B (en) Composition, method and use